Biochem. J. (2006) 396, 287–295 (Printed Great Britain)   doi:10.1042/BJ20051825                                                                               287


Phosphatidylinositol synthesis essential bloodstream form
Trypanosoma brucei
Kirstee L. MARTIN Terry K. SMITH1
Division Biological Chemistry Molecular Microbiology, School Life Sciences, University Dundee, Dundee DD1 5EH, Scotland, U.K.




PI (phosphatidylinositol) ubiquitous eukaryotic phospholipid                          gene. vivo labelling conditional double knockout cells serves precursor messenger molecules GPI                                confirmed result, showing decrease PI
(glycosylphosphatidylinositol) anchors. PI synthesized                           formed cells grown non-permissive conditions. novo head group exchange PIS (PI synthase).                              Furthermore, quantitative qualitative analysis GLC-MS
synthesis GPI anchors previously validated                                ESI-MS/MS (electrospray ionization MS/MS) respectively
genetically chemically drug target Trypanosoma                                 showed significant decrease (70  ) cellular PI, appears
brucei, causative parasite African sleeping sickness.                           affect major PI species equally. consequence fall  known synthesis PI organism.                         PI level knock reduction GPI biosynthesis Database mining revealed putative TbPIS gene T. brucei                            essential parasite’s survival. results presented genome recombinant expression characterization                               PI synthesis essential bloodstream form T. brucei, shown encode catalytically active PIS, high spe-                           knowledge report dependence cificity myo-inositol. Immunofluorescence revealed                             PI synthesis protozoan parasite genetic validation.
T. brucei, PIS endoplasmic reticulum Golgi. created conditional double knockout TbPIS                            Key words: bloodstream form, essentiality, glycosylphosphat-
bloodstream form T. brucei, grown non-                                 idylinositol, myo-inositol, phosphatidylinositol synthase (PIS),
permissive conditions, clearly showed TbPIS essential                           Trypanosoma.



INTRODUCTION                                                                                  African trypanosomiasis caused protozoan parasite
                                                                                           Trypanosoma brucei potentially fatal disease eukaryotes, PI (phosphatidylinositol) ubiquitous phospho-                          economic problem sub-Saharan Africa. unicellular
lipid forms 3 10   cell membranes, functions                           parasite able avoid host’s innate immune precursor cell signalling molecules provides basic                        undergoing antigenic variation involves switching GPI-
building block used GPI (glycosylphosphatidylinositol) anchor                           anchored VSGs (variant-surface glycoproteins) [11]. Despite biosynthesis. PI synthesized novo action PIS                            variation VSG protein, GPI core structure attached
(PI synthase; EC 2.7.8.11) using myo-inositol CDP-DAG                                  protein remains unchanged comprises NH2 CH2 CH2 PO4 H-
(CDP diacylglycerol) releasing CMP. Alternatively,                              6Manα1-2Manα1-6Manα1-4GlcNα1-6D-myo-inositol-1-HPO4 -
absence CDP-DAG, head group exchanged                                dimyristylglycerol [12]. biosynthesis GPI anchors pre-existing PI free myo-inositol. Native recombinant                              genetically chemically validated potential
PIS enzymes studied organisms including                                therapeutic drug target bloodstream form T. brucei [13–15].
Saccharomyces cerevisiae [1–4], Arabidopsis thaliana [5–7]                                PI utilized initial step GPI anchor biosynthesis,
Toxoplasma gondii [8]. PIS enzymes appear predominantly                              GlcNAc transferred UDP-GlcNAc PI form
localized ER (endoplasmic reticulum),                            GlcNAc-PI  [16] references contained . Surpris- detected cellular locations Golgi [9],                          ingly, despite essentiality GPI anchors bloodstream form
outer mitochondrial membrane S. cerevisiae [1,4] plasma                             T. brucei, little known PI biosynthesis membrane rat pituitary GH3 cells [10]. date, PIS enzymes                         parasites. synthesis PI demonstrated Plas-
require Mg2+ Mn2+ activity neutral pH optima.                              modium knowlesi [17], Plasmodium falciparum [17], Crithidia ability catalyse PI synthesis exchange                        fasciculate [18] Giardi lamblia [19], date PIS
reactions investigated PIS enzymes,                       synthesis shown essential survival clearly shown recombinant PISs organisms,                              parasites. report molecular cloning charac-
particular S. cerevisiae [2]  thaliana [6].  exact                       terization protozoan PIS  gondii, mechanism reaction physiological significance                             developmentally regulated PIS genes identified
remain unknown.                                                                            [8].


  Abbreviations used: BiP, endoplasmic reticulum luminal chaperone binding protein; DAG, diacylglycerol; DAPI, 4,6-diamidino-2-phenylindole; ER,
endoplasmic reticulum; ESI-MS, electrospray ionization MS; GPI, glycosylphosphatidylinositol; HA, haemagglutinin; HPTLC, high-performance TLC; HYG,
hygromycin phosphotransferase; IPTG, isopropyl β-D-thiogalactoside; LB, Luria–Bertani; Ni-NTA, Ni2+ -nitrilotriacetate; ORF, open reading frame; PAC,
puromycin acetyltransferase; PI, phosphatidylinositol; PLC, phospholipase C; PI-PLC, PI-specific PLC; PIS, PI synthase; TbGRASP, T. brucei Golgi matrix
protein; TbPIS, T. brucei PI synthase; TDB, trypanosome dilution buffer; Ti, tetracycline-inducible; TRITC, tetramethylrhodamine β-isothiocyanate; UTR,
untranslated region; VSG, variant-surface glycoprotein.
  1
     correspondence addressed (email T.K.Smith@dundee.ac.uk).
  nucleotide sequence reported paper submitted DDBJ, EMBL, GenBank® GSDB Nucleotide Sequence Databases accession number AJ716153.

                                                                                                                                             
                                                                                                                                             c 2006 Biochemical Society
 288             K. L. Martin T. K. Smith


   present study, report investigations PI synthesis      (0.2 × SSC 0.1   SDS). Bound probe detected using bloodstream form T. brucei, involving molecular cloning            CDP-STAR detection module (Amersham) autoradio- PIS, recombinant expression preliminary enzyme charac-           graphy.
terization.  creation conditional double          Northern blots, total RNA purified using RNeasy
knockout, PI synthesis essential survival blood-   Mini kit (Qiagen) separated formaldehyde gel trans-
stream form parasite. knowledge,         ferred Hybond N+ (Amersham). Hybridization conditions
report essentiality PI synthesis protozoan parasite.        stringency washes described Southern blotting,
                                                                         using 32 P-labelled PIS ORF probe. Bound probe                                                                          detected autoradiography.
EXPERIMENTAL
                                                                         Cultivation genetic modification T. brucei
Nucleic acid manipulations
                                                                         Bloodstream form T. brucei strain 427, pre-
Using S. cerevisiae PIS, putative PIS gene identified
                                                                         viously modified express T7 polymerase tetra- T. brucei genome database (Sanger Centre, Cambridge,
                                                                         cycline repressor protein [20], referred wild-type
U.K.) using tBlastN. ORF (open reading frame) PCR-
                                                                         cells convenience. Cells grown HMI-9 medium sup-
amplified T. brucei genomic DNA Pfu polymerase using
                                                                         plemented G418 (2.5 µg/ml), 37 ◦C 5   CO2 forward reverse primers 5 -GAGGAGAAGCTTATG-
                                                                         described [13,20–22]. Transformation conditions CCGAAAGCTAAAACT-3 5 -TCGTTAATTAACTGGCG-
                                                                         subsequent drug selection described [13,20–
GCTTCCCGCAGC-3 respectively. amplicon purified
                                                                         22]. experiments requiring tetracycline-free conditions, Tet-
(QIAquick PCR purification kit; Qiagen), cloned pCR-
                                                                         approved foetal calf serum (Clontech) used. Blunt II TOPO (Invitrogen) sequenced. Using HindIII                                                                          tetracycline added medium, final concentration PacI restriction sites (underlined primer sequences), putative
                                                                         1 µg/ml used.
TbPIS (T. brucei PIS gene) ligated tetracycline-
inducible expression vectors pLew82 pLew100 [20] HindIII PacI restriction sites.                                      Immunofluorescence
   construct T. brucei gene replacement cassettes, 5 -       Mid-exponential cells collected centrifugation (800 g,
UTR (5 -untranslated region) 3 -UTR immediately adjacent           10 min) fixed 4   (w/v) paraformaldehyde. wash- PIS ORF amplified T. brucei genomic DNA using           ing PBS, fixed cells allowed adhere poly-
Pfu polymerase. primers 5 -ATAAGAATGCGGCCGCAT-                      lysine slides prior staining DAPI (4,6-diamidino-
AATCACTTTAGCGTCGCGTGG-3 5 -GTTTAAACTTA-                            2-phenylindole; 2 µg/ml) antibodies. Cells rehydrated
CGGACCGTCAAGCTTTGGTGCTGCGTTGCTTGC-3                                PBS washed PBS–glycine (0.1 M) prior 
used 5 -UTR, primers 5 -GACGGTCCGTAAGTTTA-                 meabilization Triton X-100 (0.1  ) blocking 1  
AACGGATCCGGAGTTGTGTGTTAAAGG-3 5 -ATAA-                             BSA PBS. detect HA (haemagglutinin) tag, cells GAATGCGGCCGCATTCCACACCAATAAAAGGAGAT-3                               incubated rat monoclonal anti-HA antibody (Roche) 3 -UTR. amplified products used knitting PCR,       FITC-conjugated rabbit anti-rat immunoglobulins (DakoCyto- 5 -UTR joined 3 -UTR short BamHI–        mation). ER Golgi localization determined incubation
HindIII linker region contained described primers             1 h room temperature (∼ 20 ◦C) rabbit anti-
(italics) NotI site (underlined) end. PCR product     BiP (ER luminal chaperone binding protein) [23] rabbit ligated pGEM-5Zf(+) (Promega) NotI sites            anti-TbGRASP (T. brucei Golgi matrix protein) antibodies [24] hygromycin [HYG (hygromycin phosphotransferase)]                  respectively, prior incubation 1 h room temperature puromycin [PAC (puromycin acetyltransferase)] resistance genes           TRITC (tetramethylrhodamine β-isothiocyanate)-conjugated ligated BamHI HindIII restriction sites.            anti-rabbit immunoglobulins (Sigma).
Plasmid DNA prepared using QIAprep Miniprep Plasmid
kit (Qiagen); digestion NotI, precipitated        Recombinant expression Escherichia coli
sodium acetate/ethanol dissolved sterile water final
concentration 1 µg/µl electroporation.                            TbPIS amplified genomic DNA using primers 5 -
                                                                         GGCGATATCGGATCCCATGCCGAAAGCTAAAACT-3                                                                          5 -CCGCAAGCTTGGGCTGGCGGCTTCCCGCAGCAGCAT-
Southern Northern blots                                              CCA-3 ligated pET32b (Novagen) sites BamHI PIS ORF PCR-amplified using primers                  HindIII, underlined primer sequences. scribed previous section ligation pLew vectors       recombinant expression, freshly transformed BL21 cells gel-purified QIAquick gel extraction kit (Qiagen).           used inoculate 100 ml M9 glucose minimal medium (M9
fragment labelled fluorescein (Gene Images-         salts, 0.2   glucose, 1 mM MgSO4 0.001   thiamine) sup-
Random prime module; Amersham) Southern blotting                     plemented casamino acids (2 g/l) ampicillin (100 µg/ [α-32 P]dCTP (RediprimeII random prime labelling               ml). Cells grown 37 ◦C absorbance   600 nm
Amersham) Northern blotting.                                         0.5 0.6, induced IPTG (isopropyl
   Southern blots, genomic T. brucei DNA (2 µg) digested         β-D-thiogalactoside; 50 µM) grown overnight 25 ◦C. various restriction enzymes, digestion products            cells collected centrifugation resuspended lysis
separated 0.8   agarose gel transferred Hybond-N        buffer [50 mM sodium phosphate, pH 7, 300 mM NaCl, 5 mM
membrane (Amersham). membrane hybridized overnight               2-mercaptoethanol, 5   (v/v) glycerol, 0.1   Triton X-100, ULTRA-HYB (Ambion) 42 ◦C fluorescein-labelled             40 mM imidazole complete protease inhibitor cocktail 
PIS ORF probe. Stringency washes carried 42 ◦C,          EDTA (Roche)], disruption sonication. consisted washes low stringency 15 min (2 ×           supernatant cleared centrifugation, prewashed Ni-NTA
SSC 0.1   SDS; 1 × SSC 0.15 M NaCl 0.015 M                    (Ni2+ -nitrilotriacetate) beads (Qiagen) added mix-
sodium citrate) washes high stringency 15 min       ture incubated 4 ◦C 1 h. beads collected,


c 2006 Biochemical Society
                                                                               Phosphatidylinositol synthase Trypanosoma brucei            289


washed lysis buffer bound protein eluted lysis     resuspended medium final concentration 1 ×
buffer containing 250 mM imidazole, detected Western          107 cells/ml. Cells labelled 1 h 37 ◦C 50 µCi/
blotting using anti antibodies (Clontech).                       ml D-[2-3 H]inositol (30 Ci/mmol; Amersham) D-[2-
                                                                     3
                                                                       H]mannose (14 Ci/mmol; Amersham). cells collected
myo -[3 H]Inositol labelling E. coli cultures                     centrifugation (800 g, 10 min) lipids extracted                                                                      chloroform/methanol/water (10:10:3) 1 h, supernatant vivo labelling E. coli cells expressing TbPIS performed    removed pellet extracted chloroform/ described previously [5]. Briefly, cells grown 10 ml   methanol (2:1) 1 h. supernatants pooled dried
LB (Luria–Bertani) medium supplemented 0.1 mM myo-              stream nitrogen prior desalting using butanol/water
inositol A600 0.8, 4 ml culture        partitioning. aliquot lipid fraction taken removed, washed LB medium resuspended 2 ml              total 3 H c.p.m. lipid fraction determined LB medium supplemented 20 µM myo-inositol 1.2 µM            scintillation spectrometry using Beckman LS6000SE [3 H]myo-inositol. Expression induced 0.5 mM IPTG           Formula 989 scintillation fluid (Packard Bioscience). Lipids cells grown 37 ◦C 3 h. cells       separated HPTLC using silica 60 HPTLC plates chlo- collected centrifugation, resuspended sonication buffer   roform/methanol/water (10:10:3) solvent. Radiolabelled
(50 mM Tris/HCl, pH 8, 2 mM EDTA 0.2 mg/ml lyso-                 lipids detected fluorography − 70 ◦C, spraying
zyme) disrupted sonication, cells debris        En3 HanceTM using Kodak XAR-5 film intens- removed centrifugation (4500 g, 10 min). extract          ifying screen. [3 H]PI quantified using AR-2000 imaging
lipids, chloroform methanol added supernatant        scanner (Bioscan). achieve final concentration 10:10:3  vol.) chloroform/       labelling [35 S]methionine, 1 × 107 mid-exponential
methanol/water incubated shaking room temperature        cells collected centrifugation, washed methionine-free 1 h, samples nitrogen dried desalted        minimal essential media resuspended medium butanol/water partitioning. Lipids separated HPTLC           final concentration 1 × 107 cells/ml. cells labelled
(high-performance TLC) using silica 60 plates chloroform/       30 min 20 µCi [35 S]methionine (1175 Ci/mmol; MP
methanol/water (10:10:3) solvent. Radiolabelled lipids        Biomedicals) 37 ◦C. quench labelling, cells were detected fluorography − 70 ◦C spraying         diluted 20 ml cold TDB (trypanosome dilution buffer;
En3 HanceTM (NEN) using Kodak XAR-5 film               25 mM KCl, 400 mM NaCl, 5 mM MgSO4 , 100 mM Na2 HPO4 ,
intensifying screen.                                                 NaH2 PO4 100 mM glucose) containing 1 mM L-methionine
                                                                     centrifuged (800 g, 10 min, 4 ◦C). supernatant E. coli membrane preparation PIS enzyme assay                    removed, cells resuspended TDB, equal volume E. coli membrane purification, BL21 cells freshly transformed    2× SDS/PAGE sample buffer (100 mM Tris, pH 6.8, 2   SDS, TbPIS-pET32b vector induced grown overnight        0.1   Bromophenol Blue, 10   glycerol 5   2-mercapto- described  collection centrifugation, cells   ethanol) added heated 100 ◦C. Proteins separated
resuspended PBS disrupted sonication. Cell debris,         SDS/10   polyacrylamide gel visualized Coomassie cells ghosts removed slow-speed centrifug-         Blue staining. detect 35 S-labelled proteins, destained gel ation (14 500 g, 10 min); subsequently, membranes collected     soaked En3 HanceTM 30 min, washed water twice, high-speed centrifugation (100 000 g, 1 h), resuspended        soaked 10   glycerol dried. dried gel exposed
50 mM Tris (pH 8), 5 mM EDTA 20   glycerol stored            XAR-5 film overnight − 70 ◦C. aliquots − 20 ◦C.
   Unless stated, reaction mixture PIS activity    Enzymatic digests chemical characterization radiolabelled
consisted 50 mM Tris/HCl (pH 8), 0.15 mM CDP-DAG (Avanti          lipid species
Polar Lipids), 0.3   n-octyl glucopyranoside, 2 µCi [3 H]myo-     Digestion PI-PLC [PI-specific PLC (phospholipase C);
inositol (Amersham; 14 Ci/mmol), 2.5 mM MnCl2 , 20 mM                Glyko], deamination, base hydrolysis HF (hydrogen fluoride)
MgCl2 50 µg membrane protein, final volume            treatment described previously [25–27].
100 µl. reaction conditions used investigate sub-
strate recognition various isomers analogues inositol 25 µM 1 mM. Reaction mixtures incubated 30 ◦C         Inositol analysis 1 h terminated addition 666 µl chloro-          Mid-exponential cells collected centrifugation (800 g,
form/methanol (1:1, v/v). Lipid extractions separations     10 min), washed TDB stored − 20 ◦C. Lipids performed described [3 H]myo-inositol labelling E. coli    extracted samples addition 500 µl chloro-
cells. [3 H]PI quantified using AR-2000 imaging scanner       form/methanol mixture (2:1) incubated room temperature
(Bioscan).                                                           1 h. supernatant removed pellet 
   reaction mixture used investigate exchange reaction    extracted chloroform/methanol/water mixture (1:2:0.8). based Klezovitch et al. [2] contained 50–100 µg   supernatants pooled dried nitrogen prior membrane protein, 0.5 µM PI (soya bean; Sigma), 2 µCi          desalting biphasic partitioning using 2:1 (v/v) butanol/water.
[3 H]myo-inositol, 25 mM MnCl2 , 50 mM MgCl2 100 mM              internal standard D6 myo-inositol added samples prior
Tris/HCl (pH 8) CMP (4 mM).                   hydrolysis strong acid (6 M HCl, 110 ◦C), derivitization                                                                      TMS [trimethylsilyl (Me3 Si)] analysis GLC-MS, vivo T. brucei metabolic labelling                                method Ferguson [28]. myo-Inositol quantified                                                                      means separate analyses determined. results presented vivo metabolic labelling repres-
entative independent experiments errors 5  . metabolic labelling, 2 × 107 mid-exponential cells   ESI-MS
(1 × 106 cells/ml) centrifuged (800 g, 10 min), washed       Mid-exponential cells collected centrifugation (800 g,
inositol-free minimal essential medium [15,25,26],      10 min), washed PBS resuspended PBS. Lipids

                                                                                                                        
                                                                                                                        c 2006 Biochemical Society
 290              K. L. Martin T. K. Smith




Figure 1 Clustal W alignment predicted amino acid sequence TbPIS (AJ716153) S. cerevisiae (S. cere, GenBank® accession  J02697),  gondii (AF069132)  thaliana (AJ000539)
Identical residues shown reverse type black background. Predicted transmembrane domains TbPIS underlined.

 extracted method Bligh Dyer [29]. Qualitative                                  TMPRED form.html). putative TbPIS contains 
analysis lipids performed ESI-MS (electrospray                                          fect copy motif [DG(X)2 AR(X)8 G(X)3 D(X)3 D] ionization MS) ESI-MS/MS nanospray tips (Micromass                                       residues 55 78, described phos-
type F) using Micromass Quattro Ultima triple quadrupole mass                                   pholipid-synthesizing enzymes identified date. TbPIS spectrometer argon [3.0 × 10−3 Torr (1 Torr = 133.3 Pa)]                                  submitted GenBank® Nucleotide Sequence Database collision gas. capillary voltage 0.9 kV used                                accession number AJ716153.
positive- negative-ion modes. Cone voltages 50 30 V used positive- negative-ion modes respecttively. analysis inositol-phospholipids, negative-ion parent ion scann-                                Recombinant expression
ing m 241 (corresponding collision-induced fragment                                   confirm enzymatic activity putative TbPIS, inositol-1,2-cyclic phosphate) used collision energy                                  expressed E. coli using pET32b vector encodes N-
45 V.                                                                                             C-terminal His6 tags. production tagged protein
                                                                                                  correct molecular mass (38 kDa) confirmed Western
RESULTS DISCUSSION                                                                            blotting detection anti antibodies (Figure 2A).
                                                                                                     E. coli possess endogenous PIS activity, 
Cloning TbPIS
                                                                                                  combinant TbPIS activity confirmed methods. Firstly, putative PIS identified T. brucei genome database                                    vivo [3 H]myo-inositol labelling E. coli cells ex-
using S. cerevisiae PIS query. putative TbPIS                                     pressing TbPIS (Figure 2B) undertaken, [3 H]myo-
ORF amplified sequence confirmed. pre-                                        inositol lipid species present cell extracts E.
dicted molecular mass deduced amino acid sequence                                       coli cells expressing TbPIS (Figure 2B, lane 1). [3 H]myo-
24 kDa; alignment deduced amino acid sequence                                      inositol lipid species Rf (retention factor) identical deduced PIS proteins organisms shown Figure 1.                                   PI; characterization showed sensitive PI- PISs (e.g. 1, 5 8), TbPIS contains                                 PLC, base hydrolysis HF treatment (results shown). putative transmembrane domains (underlined Figure 1) pre-                                   results consistent [3 H]myo-inositol species PI
dicted TMHMM (http://www.cbs.dtu.dk/services/TMHMM-                                            clearly putative TbPIS catalytically active
2.0/)       Tmpred      (http://www.ch.embnet.org/software/                                   PIS.


c 2006 Biochemical Society
                                                                                                           Phosphatidylinositol synthase Trypanosoma brucei            291


                                                                                                  CDP-DAG (results shown). assay conditions
                                                                                                  used present study, K m (app) myo-inositol                                                                                                   2 µM (Figure 2C). significantly lower                                                                                                   reported native PISs Chlamydomonas reinhardtii
                                                                                                  (0.2 mM) [30], turkey erythrocyte membranes (0.3 mM) [31],
                                                                                                  human placenta (0.28 mM) [32] yeast (0.1 mM) [1].
                                                                                                     Like previously described PISs [2,6], recombinant TbPIS
                                                                                                  able catalyse head group exchange inositol pre-
                                                                                                  existing PI (soya bean) free [3 H]myo-inositol; activity
                                                                                                  detected absence CMP greatly enhanced
                                                                                                  (∼ 5-fold) presence 4 µM CMP (results shown).
                                                                                                     specificity TbPIS investigated respect                                                                                                   myo-inositol; various inositol isomers analogues added
                                                                                                  standard assay mixture ability compete                                                                                                   [3 H]myo-inositol form [3 H]PI determined (Figure 2D).
                                                                                                  25 µM (12.5 times K m ) myo-inositol added                                                                                                   standard reaction mixture, incorporation [3 H]myo-
                                                                                                  inositol [3 H]PI decreased approx. 15   normal                                                                                                   expected, showing unlabelled myo-inositol competing
                                                                                                  [3 H]myo-inositol.  isomers
                                                                                                  inositol [muco-, neo-, epi-, D(+)-chiro-, L(−)-chiro, cis-,
                                                                                                  allo- scyllo-] inositol analogues  Supplementary
                                                                                                  Figure S1 http://www.BiochemJ.org/bj/396/bj3960287add.htm
                                                                                                  structures) able affect incorporation [3 H]myo-
                                                                                                  inositol [3 H]PI. 1 mM, neo-, epi-, L(−)-chiro-,
                                                                                                  allo-, scyllo-, 1-deoxy-1-fluoro-scyllo-, 2-OMe-myo-, 1-deoxy-1-
                                                                                                  fluoro-myo-, 3-deoxy-3-fluoro-myo- D6 -myo-inositol caused
                                                                                                  reduction incorporation [3 H]myo-inositol [3 H]PI,
                                                                                                  suggesting high concentration able
                                                                                                  interact TbPIS. findings, propose
                                                                                                  orientation 1-, 3- 4-hydroxyls im-
                                                                                                  portant represents minimum recognition motif shown
                                                                                                  Supplementary Figure S1 http://www.BiochemJ.org/bj/
                                                                                                  396/bj3960287add.htm.


Figure 2 Expression TbPIS E. coli biochemical                                      synthesis PI essential bloodstream form T. brucei
characterization                                                                                  PIS appeared single copy gene haploid genome T.
  TbPIS cloned expression vector pET32b expressed BL21 E. coli              brucei genome sequence database (Sanger Centre), cells. Recombinant protein purified lysed cells presence detergent using       confirmed Southern blot analysis  Supplementary Fig-
Ni-NTA beads. Purified protein run SDS/10   polyacrylamide gel, transferred             ure S2 http://www.BiochemJ.org/bj/396/bj3960287add.htm). nylon membrane Western blotting detected using anti antibodies. Arrow            schematic representation strategy employed 
indicates purified tagged TbPIS. (B) E. coli cells expressing TbPIS (lane 1) unrelated     struction conditional double knockout bloodstream form
protein (lane 2) labelled vivo [3 H]myo -inositol, lipids extracted separated HPTLC described text. [3 H]myo -Inositol-labelled lipids detected
                                                                                                  T. brucei shown Figure 3 . autoradiography; arrow indicates [3 H]myo -inositol-labelled PI. (C) Kinetics recombinant      Attempts create double null mutant TbPIS 
TbPIS myo -inositol. Enzyme activity measured described Experimental section;   successful, suggesting TbPIS essential gene  Sup-
CDP-DAG concentration held constant (0.15 mM) inositol concentration varied. Inset        plementary data).  allow creation conditional
shows Lineweaver–Burk plot data. (D) Ability TbPIS utilize inositol isomers     double knockout cell line, Myc-tagged ectopic copy TbPIS
chemically modified inositol form PI. Compound 1, muco -; compound 2, neo -; compound 3,       integrated PIS::PAC cell line pLew100 vec-
epi -; compound 4, D(+)-chiro -; compound 5, L(−)-chiro ; compound 6, cis -; compound 7,
allo -; compound 8, scyllo -; compound 9, myo -; compound 10, 2-OMe-chiro -; compound 11,
                                                                                                  tor [30]. integration ectopic copy success-
1-deoxy-1-fluoro-scyllo -; compound 12, 2-OMe-myo -; compound 13, 1-deoxy-1-fluoro-myo -;         ful, attempts delete second TbPIS allele 
compound 14, 3-deoxy-3-fluoro-myo -; compound 15, 3-deoxy-3-azido-myo -; compound 16,             successful  Supplementary data, Figures S3 S4 http://
myo -inositol-2-phosphate; compound 17, DL-1,2-anhydro-myo -inositol; compound 18,                www.BiochemJ.org/bj/396/bj3960287add.htm). possibility
D6-myo -inositol; compound 19, myo -inositol-1-phosphate; compound 20,  Supple-          postulated C-terminal Myc tag encoded mentary Figure S1 http://www.BiochemJ.org/bj/396/bj3960287add.htm structures).             pLew100 vector interfering TbPIS localization
White area represents percentage [3 H]PI formed compounds used 25 µM, black area represents percentage [3 H]PI formed compounds used 1 mM.
                                                                                                  activity. Myc tag exchanged HA determinations performed triplicate.                                                  tag, separate experiments appeared hinder                                                                                                   transcription/translation TbPIS.
                                                                                                     HA-tagged ectopic copy electroporated   Secondly, cell-free using membranes isolated E.                                   PIS::PAC cell line using modified pLew100-HA vector coli expressing TbPIS used subsequent biochemical                                     clones selected puromycin phleomycin. characterization recombinant protein. conditions                                 PIS::PAC PIS-HATi clones  ‘Ti’ tetracycline-inducible)
used, PIS activity linear 2 h (results                                 obtained integration ectopic copy initially
shown), optimal pH range 7–8 (results shown).                                  confirmed PCR using primers specific pLew100 vector
TbPIS catalytic activity dependent presence Mg2+                                    (results shown) later Southern blotting (Figure 3B,

                                                                                                                                                    
                                                                                                                                                    c 2006 Biochemical Society
 292                K. L. Martin T. K. Smith




Figure 3      Construction PIS conditional double knockout cell line
  Schematic representation construction strategy used.   allele PIS replaced puromycin resistance gene (PAC) homologous recombination, generating PIS::PAC cell
line, (ii) tetracycline-inducible ectopic copy PIS introduced rDNA, generating
PIS-HA Ti PIS::PAC cell line, (iii) tetracycline induces expression ectopic copy, remaining allele replaced hygromycin resistance gene homologous recom-
bination, resulting conditional double knockout cell line PIS-HA Ti PIS::PAC/PIS::HYG .
(B) Confirmation genotype T. brucei PIS conditional double knockout cell line. Southern-blot
analysis HinfI-digested genomic DNA (∼ 2 µg) wild-type T. brucei cells (lane 1),
PIS::PAC (lane 2), PIS-HA Ti PIS::PAC (lane 3) PIS-HA Ti PIS::PAC/PIS::HYG
(lane 4) cells; PIS ORF probe shows allelic TbPIS 1 kb ectopic copy TbPIS-HA Ti approx. 1.2 kb.

                                                                                                      Figure 4 Growth curves Northern blot TbPIS conditional double
lane 3). Transcription ectopic copy induced ad-                                        knockout cell line
dition tetracycline medium prior deletion                                                                                                       Cells washed tetracycline-free HMI-9, transferred tetracycline-free medium
second allele TbPIS. Deletion endogenous alleles                                       counted daily; experiments performed independent occasions, set confirmed Southern blotting, resulting cell line PIS::                                     data shown representative experiments. Growth curves shown wild-type
PAC/PIS::HYG/PIS-HATi (Figure 3B, lane 4).                                                            cells medium  , TbPIS conditional double knockout added tetracycline (B),    conditional double knockout PIS::PAC/PIS::HYG/PIS-                                            TbPIS conditional double knockout tetracycline (C). (D) Figure shows Northern
HATi cell line used investigate dependence blood-                                       blot total RNA procyclic cells (lane 1), wild-type cells (lane 2), TbPIS conditional
                                                                                                      double knockout tetracycline day 2 (lane 3), TbPIS conditional double knockout stream form cells synthesis PI. washed
                                                                                                      tetracycline day 2 (lane 4) TbPIS conditional double knockout tetracycline times tetracycline-free medium, cells incubated                                         day 14 (lane 5). blot probed TbPIS ORF β-tubulin, detailed medium absence presence tetra-                                        Experimental section.
cycline. initial concentration cells 5 × 104 ml−1 cells diluted concentration                                        tetracycline 2 days, detectable transcript 1 3 × 106 ml−1 , normally second day.                                         TbPIS ectopic copy.  cells spontaneously
conditional double knockout cells displayed normal growth                                             resumed growth absence tetracycline, clear
rates presence tetracycline compared wild-                                        TbPIS transcript (Figure 4D, lane 5). suggests type cells (Figures 4A 4B). absence tetracycline,                                       revertent cells able overcome tetracycline control, cells grew normally 2 days;                                      enabling cells resume expression TbPIS. spon-
time, cell numbers decreased distinct morphological change                                      taneous recovery T. brucei conditional double knockout cell observed  Supplementary Figure S5 http://www.                                              lines grown absence tetracycline described BiochemJ.org/bj/396/bj3960287add.htm); concurrently increas-                                          essential genes [13,21,22] loss tetracycline
ing levels cell debris observed, suggesting cell death                                        control, case shown deletion (Figure 4C).  9–10 days absence tetra-                                        tetracycline repressor gene [22].
cycline, live cells observed, suggesting small propor-
tion dying cells able spontaneously resume normal
                                                                                                      Biochemical phenotype TbPIS conditional knockout cells
growth rates. determine adaptation
(e.g. uptake sufficient PI extracellular environment)                                     biochemical phenotype TbPIS conditional knockout expression TbPIS ectopic copy, transcription                                      cells investigated quantitative qualitative analyses
levels TbPIS investigated. culturing absence                                  inositol-phospholipids GLC-MS MS respectively 

c 2006 Biochemical Society
                                                                                                                  Phosphatidylinositol synthase Trypanosoma brucei                               293




                                                                                                     Figure 6 Biochemical phenotype analyses TbPIS conditional
                                                                                                     knockout cells
                                                                                                     Prior labelling, cells grown tetracycline-free medium 2 days; tetracycline
Figure 5      PI analyses TbPIS conditional double knockout cells                                 necessary, added daily 1 µg/ml.   Cells labelled [3 H]myo -inositol,
                                                                                                     lipids extracted detected detailed Experimental section. Lane 1, wild-type cells;
  Lipid myo -inositol levels quantified GLC-MS detailed text                lane 2, TbPIS conditional double knockout cells grown presence tetracycline; lane 3,
wild-type cells (cell line 1), TbPIS conditional double knockout cells grown presence      TbPIS conditional double knockout cells grown absence tetracycline. (B) Cells tetracycline (cell line 2) TbPIS conditional double knockout cells grown absence          labelled [35 S]methionine, protein samples prepared, separated detected tetracycline (cell line 3); 100   represents 55 pmol myo -inositol/5 × 104 cell equivalents.   using autoradiography (lanes 1–4) Coomassie Blue staining (lanes 5–8). Lanes 1 5,
Inositol-phospholipids qualitatively analysed ESI-MS/MS using parent-ion scanning            wild-type cells pre-incubated 5 min 60 µg/ml cycloheximide prior labelling; lanes 2 m  241  collision-induced fragment PI, inositol-1,2-cyclic phosphate) negative ion    6, wild-type cells; lanes 3 7, TbPIS conditional double knockout cells grown mode (B) wild-type cells (C) TbPIS conditional double knockout cells grown         presence tetracycline; lanes 4 8, TbPIS conditional double knockout cells grown absence tetracycline.                                                                         absence tetracycline. (C) Cells labelled [3 H]mannose, lipids extracted
                                                                                                     detected detailed Experimental section. Lane 1, wild-type cells; lane 2, TbPIS
                                                                                                     conditional double knockout cells grown absence tetracycline. vivo labelling. analyses, conditional double
knockout cells grown absence presence tetra-                                       change ratios peaks conditional double knockout
cycline 2 days results compared                                     cells grown non-permissive conditions 2 days wild-type cells grown conditions.                                                     compared wild-type cells (compare Figures 5B 5C).
   Total phospholipids extracted wild-type cells                                        apparent change phospholipids conditional double knockouts grown presence                                         determined ESI-MS (results shown). results coupled
absence tetracycline 2 days myo-inositol                                    GLC-MS analysis overall decrease determined GLC-MS. shown Figure 5 ,                                         inositol-containing phospholipids, ap- slight decrease lipid containing myo-inositol                                     peared affect species similar extent. reduction conditional double knockouts grown presence                                         PI detrimental effect cell signalling GPI
tetracycline compared wild-type cells.                                     anchor biosynthesis. ectopic copy PIS enzymatically                                        vivo labelling [3 H]myo-inositol suggested total
efficient HA tag regulated                                        radioactivity incorporated lipid fraction level endogenous PIS. conditional double                                        conditional double knockout cells grown presence knockout cells grown absence tetracycline                                         absence tetracycline reduced approx. 90 27  
2 days, significant decrease lipid-                                     respectively compared wild-type cells. Analysis bound myo-inositol approx. 30   present wild-type                                      [3 H]lipids HPTLC revealed [3 H]lipid, cells (Figure 5A).                                                                                   identical Rf PI (Figure 6A, lanes 1–3). results,    ascertain global decrease PI species                                  GLC-MS myo-inositol analysis, conditional double knockout cells grown non-permiss-                                       conditional double knockout cells grown absence
ive conditions, specific species decreased, inositol-                                 tetracycline, PI synthesis substantially decreased, phospholipids qualitatively analysed ESI-MS/MS using                                         confirming deleted gene functional PIS bloodstream
parent-ion scanning m 241 negative ion mode, indicative                                  form T. brucei.  residual PIS activity remained
collision-induced fragment PI species (inositol-1,2-cyclic                                    cells account [3 H]PI, albeit reduced
phosphate). peaks identified C18:0 /C18:2 C18:0 /C22:4 ;                             level. detectable TbPIS mRNA detectable previously identified major forms DAG PI                                        removal tetracycline 2 days (Figure 4D, lane 4), bloodstream form T. brucei [33,34]. significant                                    time total cellular PIS loss protein turnover

                                                                                                                                                                         
                                                                                                                                                                         c 2006 Biochemical Society
 294               K. L. Martin T. K. Smith




Figure 7     Subcellular localization PIS–HATi bloodstream form T. brucei cells
Cells expressing PIS–HATi stained HA epitope cellular markers. staining antibodies Golgi protein TbGRASP shown  E).   Phase contrast image;
(B) DAPI staining; (C) HA epitope staining FITC detection; (D) TbGRASP staining TRITC detection; (E) merged image HA detection TbGRASP detection. staining antibodies ER protein BiP shown (F–J). (F) Phase contrast image; (G) DAPI staining; (H) HA epitope staining FITC detection;   BiP staining TRITC detection; (J) merged
image HA detection BiP detection.

 dilution cell division, explaining cells                                     biosynthesis slowed greater 90  , parasites die alive point.                                                                         [13–15].
   confirm cells viable point labell-
ing, ability synthesize protein investigated parallel myo-inositol vivo labelling. wild-type cells                                     TbPIS localized ER Golgi
able incorporate significant [35 S]methionine                                     investigate subcellular location PIS T. brucei blood-
newly synthesized protein (Figure 6B, lane 2) compared                                        stream form cells, tetracycline-inducible ectopic copy intro- pretreated cycloheximide, known protein synthesis                                        duced rRNA locus using expression vector pLew82,
inhibitor (Figure 6B, lane 1). conditional knockout cells                                         encodes C-terminal HA tag. Integration ectopic
grown presence absence tetracycline 2 days showed                                    copy confirmed PCR, Southern Northern blotting
similar amounts [35 S]methionine incorporation compared                                         (results shown). Primarily cell line (TbPIS-HATi ) wild-type cells (Figure 6B, compare lanes 2–4), indicating                                       used immunofluorescence results presented  point vivo labelling, cells able syn-                                    conditional double knockout cell line PIS::
thesize protein. vivo labelling clearly shows                                       PAC/PIS::HYG/PIS-HATi created, immunofluorescent detec- PIS conditional double knockout cells grown                                        tion HA tag repeated identical non-permissive conditions 2 days, ability synthesize                                     observed TbPIS-HATi cell line. Transcription PI decreased direct result deletion PIS                                    TbPIS-HATi ectopic copy induced addition tetra- cells lost viability.                                                                cycline medium. TbPIS–HATi protein detected
   investigate knock effects decrease PI                                          immunofluorescence using primary antibody HA
synthesis, status GPI biosynthesis assessed.                                       tag secondary antibody FITC-conjugated. ditional double knockout cells grown absence presence                                       concomitant signals observed (Figures 7C 7H); tetracycline 2 days labelled [3 H]myristate                                      distinct signal positioned nucleus kinetoplast,
[3 H]mannose compared labelled wild-type cells.                                         suggesting Golgi location. second reticular cyto-
labelled [3 H]myristate, cell lines (wild-type,                                        plasmic signal perinuclear staining indicative ER.
conditional double knockout tetracycline) showed                                         cells stained rat antibodies similar amounts 3 H-labelled lipid species (results                                            HA epitope rabbit antibodies TbGRASP, known
shown), suggesting deletion PIS detri-                                         Golgi protein [24], observed complete overlap mental effects general lipid biosynthesis time point.                                      signals, suggesting TbPIS Golgi vivo [3 H]mannose labelling wild-type cells showed                                      (Figure 7E). stained cells rat antibodies
expected mature GPI glycolipids C (Figure 6C)                                        HA epitope rabbit antibodies T. brucei described previously [35,36]. conditional double                                        ER-luminal protein BiP [23]. proteins displayed reticular
knockout cells grown non-permissive conditions com-                                        staining cytoplasm, perinuclear stain-
pared wild-type cells, significant decrease                                   ing. significant localization TbPIS labelled glycolipids C (Figure 6C).                                          BiP, suggesting TbPIS ER (Figure 7J).
shows decrease PI synthesis deletion PIS                                    Localization TbPIS ER totally unexpected; direct knock effect GPI biosynthetic pathway.                                     date PISs organisms predominately, vivo labelling [3 H]myo-inositol showed PIS                                     cases solely, ER (e.g. [4,31,32]). secondary
activity decreased, residual activity remaining                                    location TbPIS Golgi consistent localization (Figure 6A). remaining PIS activity continue                                            yeast PIS, ER Golgi [1,9].
decrease PI synthesis ceases reaches critical point insufficient PI available GPI synthesis. result,
newly synthesized GPI-anchored VSG decrease,                                             Conclusions
situation previously suggested lethal                                      identity putative TbPIS identified T. brucei genome
parasite [13–15]. similar chemical genetic                                         confirmed preliminary characterization recombinant
validation T. brucei GPI pathway, soon GPI                                         protein expressed E. coli. TbPIS ER 

c 2006 Biochemical Society
                                                                                                                  Phosphatidylinositol synthase Trypanosoma brucei                            295


Golgi bloodstream form parasite. cre-                                       14 Nagamune, K., Nozaki, T., Maeda, Y., Ohishi, K., Fukuma, T., Hara, T., Schwarz, R. ation conditional double knockout, TbPIS gene shown                                         Schneider, P. (2000) Critical roles glycosylphosphatidylinositol Trypanosoma essential gene bloodstream form T. brucei, gen-                                         brucei . Proc. Natl. Acad. Sci. U.S  97, 10336–10341
etically validating particular enzyme potential drug target                                 15 Smith, T. K., Crossman, , Brimacombe, J. S. Ferguson, M.  J. (2004) Chemical
                                                                                                         validation GPI biosynthesis drug target African sleeping sickness. EMBO J. African sleeping sickness potentially diseases
                                                                                                         23, 4701–4708
caused protozoa. Quantitative qualitative analyses                                     16 Ferguson, M.  J., Brimacombe, J. S., Brown, J. R., Crossman, , Dix, , Field, R. , vivo metabolic labelling conditional double knockout                                        G¨uther, M. L. S., Milne, K. G., Sharma, D. K. Smith, T. K. (1999) GPI biosynthetic
cells confirmed significant decrease                                         pathway therapeutic target African sleeping sickness. Biochim. Biophys. Acta
major PI species cell. decrease detrimental                                            1455, 327–340
effect GPI biosynthesis, ultimately lethal                                       17 Elabbadi, N., Ancelin, M. Vial, H. (1994) Characterisation phosphatidylinositol parasite.                                                                                            synthase evidence polyphosphoinositide cycle Plasmodium -infected
   Genetic validation PI synthesis anti-trypanosomal                                            erythrocytes. Mol. Biochem. Parasitol. 63, 179–192
target demonstrates bloodstream form parasite                                         18 Daniels, C. J. Palmer, F. B. (1980) Biosynthesis phosphatidylinositol Crithidia
                                                                                                         fasciculate . Biochim. Biophys. Acta 618, 263–272 compensate loss novo synthesis scavenging
                                                                                                      19 Subramanian, , Navarro, S., Carrasco, R. , Marti, M. Das, S. (2000) Role environment vitro. results suggest                                           exogenous inositol phosphatidlyinositol glycosylphosphatidylinositol anchor
biosynthetic steps upstream PI synthesis potential                                        synthesis GP49 Giardia lamblia . Biochim. Biophys. Acta 1483, 69–80
drug targets, hypothesis currently investigating.                                            20 Wirtz, E., Leal, S., Ochatt, C. Cross, G.  M. (1999) tightly regulated inducible
                                                                                                         expression conditional gene knock-outs dominant-negative genetics work supported Wellcome Trust Senior Research Fellowship 067441.                        Trypanosoma brucei . Mol. Biochem. Parasitol. 99, 89–101
thank Graham Warren (Department Cell Biology, Ludwig Institute Cancer Research,                21 Milne, K. G., G¨uther, M. L. S. Ferguson, M.  J. (2001) Acyl-CoA binding protein Yale University School Medicine, New Haven, CT, U.S ) TbGRASP antibody                      essential bloodstream form. T brucei . Mol. Biochem. Parasitol. 112, 301–304 Jay Bangs (Department Medical Microbiology Immunology, University                       22 Roper, J. R., G¨uther, M. L., Milne, K. G. Ferguson, M.  J. (2002) Galactose
Wisconsin-Madison Medical School, Madison, WI, U.S ) BiP antibody.                             metabolism essential African sleeping sickness parasite Trypanosoma brucei .
                                                                                                         Proc. Natl. Acad. Sci. U.S  99, 5884–5889
                                                                                                      23 Bangs, J. D., Uyetake, L., Brickman, M. J., Balber,  E. Boothroyd, J. C. (1993)
REFERENCES
                                                                                                         Molecular cloning cellular localization BiP homologue Trypanosoma brucei.
 1 Fischl,  S. Carman, G. M. (1983) Phosphatidylinositol biosynthesis                           Divergent ER retention signals lower eukaryote. J. Cell Sci. 105, 1101–1113
   Saccharomyces cerevisiae : purification properties microsome-associated                     24  C. Y., Ho, H. H., Malsam, J., Chalouni, C., West, C. M., Ullu, E., Toomre, D.    phosphatidylinositol synthase. J. Bacteriol. 154, 304–311                                             Warren, G. (2004) Golgi dulplication Trypanosoma brucei . J. Cell Biol. 165, 313–321
 2 Klezovitch, O., Brandenburger, Y., Geindre, M. Deshusses, J. (1993) Characterization           25 G¨uther, M. L. S. Ferguson, M.  J. (1995) role inositol acylation inositol
   reactions catalysed yeast phosphatidylinositol synthase. FEBS Lett. 320, 256–260                deacylation GPI biosynthesis Trypanosoma brucei . EMBO J. 14, 3080–3093
 3 Nikawa, J., Kodaki, T. Yamashita, S. (1988) Expression Saccharomyces                    26 G¨uther, M. L. S., Masterson, W. J. Ferguson, M.  J. (1994) effects    cerevisiae PIS gene synthesis phosphatidylinositol Escherichia coli .                       phenylmethylsulfonyl fluoride inositol-acylation fatty acid remodelling African
   J. Bacteriol. 170, 4727–4731                                                                          trypanosomes. J. Biol. Chem. 269, 18694–18701
 4 Nikawa, J. Yamashita, S. (1997) Phosphatidylinositol synthase yeast.                      27 Smith, T. K., Cottaz, S., Brimacombe, J. S. Ferguson, M.  J. (1996) Substrate
   Biochim. Biophys. Acta 1348, 173–178                                                                  specificities dolicol phosphate mannose: glucosaminyl phosphatidylinositol
 5 Collin, S., Justin, , Cantrel, C., Arondel, V. Kader, J. (1999) Identification AtPIS,      α1-4-mannosyltransferase glycosylphosphatidylinositol biosynthetic pathway    phosphatidylinositol synthase Arabidopsis . Eur. J. Biochem. 262, 652–658                        African trypanosomes. J. Biol. Chem. 271, 6476–6482
 6 Justin, , Kader, J. Collin, S. (2002) Phosphatidylinositol synthesis exchange         28 Ferguson, M.  J. (1993) GPI membrane anchors: isolation analysis.    inositol head catalysed single phosphatidylinositol synthase 1                    Glycobiology: Practical Approach (Fukuda, M. Kobata, , eds.), pp. 349–383,
   Arabidopsis . Eur. J. Biochem. 269, 2347–2352                                                         IRL Press, Oxford, U.K.
 7 Justin, , Kader, J. Collin, S. (2003) Synthetic capacity Arabidopsis                      29 Bligh, E. G. Dyer, W. J. (1959) rapid method total lipid extraction    phosphatidylinositol synthase 1 expressed Escherichia coli . Biochim. Biophys. Acta                purification.  J. Biochem. Physiol. 37, 911–917
   1634, 52–60                                                                                        30 Blouin, , Lavezzi, T. Moore, T. S. (2003) Membrane lipid biosynthesis  8 Seron, K., Dzierszinski, F. Tomavo, S. (2000) Molecular cloning, functional                       Chlamydomonas reinhardtii . Partial characterization CDP-diacylglycerol:myo -inositol
   complementation Saccharomyces cerevisiae enzymatic properties                               3-phophatidyltransferase. Plant Physiol. Biochem. 41, 11–16
   phosphatidylinositol synthase protozoan parasite Toxoplasma gondii .                      31 McPhee, F., Lowe, G., Vaziri, C. Downes, C. P. (1991) Phosphatidylinositol synthase
   Eur. J. Biochem. 267, 6571–6579                                                                       phosphatidylinositol/inositol exchange reactions turkey erythrocyte membranes.
 9 Leber, , Hrastnik, C. Daum, G. (1995) Phospholipid-synthesizing enzymes Golgi                Biochem. J. 275, 187–192
   membranes yeast, Saccharomyces cerevisiae . FEBS Lett. 18, 271–274                          32 Antonsson, B. (1994) Purification characterization phosphatidylinositol synthase
10 Imai,  Gershengorn, M. C. (1987) Independent phosphatidylinositol synthase                   human placenta. Biochem. J. 297, 517–522
   pituitary plasma membrane endoplasmic reticulum. Nature (London) 325,                          33 Patnaik, P. K., Field, M. C., Menon,  K., Cross, G. , Yee, M. C. Butikofer, P. (1993)
   726–728                                                                                               Molecular species analysis phospholipids Trypanosoma brucei bloodstream 11 Cross, G.  M. (1996) Antigenic variation trypanosomes: secrets surface slowly.                   procyclic forms. Mol. Biochem. Parasitol. 58, 97–105
   BioEssays 18, 283–287                                                                              34 Doering, T. L., Pessin, M. S., Hart, G. W., Raben, D. M. Englund, P. T. (1994) fatty
12 Ferguson, M.  J. (1999) structure, biosynthesis functions                                acids unremodelled trypanosome glycosyl-phosphatidylinositols. Biochem. J. 299,
   glycosylphosphatidylinositol anchors, contributions trypanosome research.                  741–746
   J. Cell Sci. 112, 2799–2809                                                                        35 Menon,  K., Mayor, S., Ferguson, M. , Duszenko, M. Cross, G.  (1998)
13 Chang, T., Milne, K. G., G¨uther, M. L. S., Smith, T. K. Ferguson, M.  J. (2002)                Candidate glycophospholipid precursor glycosylphosphatidylinositol membrane
   Cloning Trypansoma brucei Leishmania major genes encoding                              anchor Trypanosoma brucei variant surface glycoproteins. J. Biol. Chem. 263,
   GlcNAc-phoshatidylinositol N-acetylase glycosylphosphatidylinositol biosynthesis                1970–1977
   essential African sleeping sickness parasite. J. Biol. Chem. 277,                   36 Mayor, S., Menon,  K. Cross, G.  M. (1992) Galactose containing
   50176–50182                                                                                           glycosylphosphatidylinositols Trypanosoma brucei . J. Biol. Chem. 267, 754–761


Received 14 November 2005/3 February 2006; accepted 14 February 2006
Published BJ Immediate Publication 14 February 2006, doi:10.1042/BJ20051825




                                                                                                                                                                        
                                                    